CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving Nivolumab

Clinical trial NCT05564923 · UNKNOWN

Trial details

NCT number: NCT05564923
Sponsor: Namik Kemal University
Status: UNKNOWN
Study type: OBSERVATIONAL

Nivolumab Related Toxicity

Start date: 2022-09-02
Primary completion: 2023-06-17
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.